Subscribe to blog Subscribe via RSS

ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Cobistat

Posted by on in New ARV Treatment, clinical trials emerging therapy
  • Font size: Larger Smaller
  • Hits: 11272
  • Print

The new "booster" drug, COBISTAT, is part of the "QUAD" single pill (see QUAD post) and a number of studies are in planning and in progress looking at the use of this agent. It may allow new regimens such as a once daily combination pill with a protease inhibitor for the first time.

Tagged in: CROI2012
Trackback URL for this blog entry.
  • No comments made yet. Be the first to submit a comment

Leave your comment

Guest
Guest Tuesday, 23 July 2019

RT @GregDore2: Crucial to continue the momentum of GP care for people with #HCV. In 🇦🇺 more than 6,000 GPs have prescribed DAA therapy sinc…

ASHM ASHM

RT @WHO: In 1991 the #HIV movement was branded with the iconic red ribbon. New York-based artists from the @Visual_AIDS Artists' Caucus cre…

ASHM ASHM